Haohua Chemical Science & Technology Corp., Ltd.

SSE:600378.SS

27.42 (CNY) • At close April 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997
Revenue 7,852.3799,067.537,424.3545,422.2654,700.6864,181.829526.858391.545473.61607.686684.359657.015615.304490.718507.019602.723495.16368.268291.405280.395193.243152.177142.808138.653128.38192.912117.357
Cost of Revenue 5,815.016,864.9925,406.4453,886.1743,356.2482,882.93372.696283.026346.596408.907486.393470.516454.487354.094358.073447.801369.737282.003239.656233.081131.968115.973103.504102.65397.51766.46192.418
Gross Profit 2,037.3692,202.5382,017.9091,536.091,344.4381,298.899154.162108.519127.014198.779197.966186.499160.817136.624148.946154.921125.42386.26551.74947.31461.27536.20539.3043630.86426.45224.939
Gross Profit Ratio 0.2590.2430.2720.2830.2860.3110.2930.2770.2680.3270.2890.2840.2610.2780.2940.2570.2530.2340.1780.1690.3170.2380.2750.260.240.2850.213
Reseach & Development Expenses 637.366641.884542.715423.188353.247310.77223.27620.61720.79320.44421.45422.06917.42811.960000000000000
General & Administrative Expenses 106.69698.34585.20975.82780.989114.1518.637.4438.8379.01412.52311.54210.08810.79463.81158.88648.61960.18614.47459.91219.33310.1737.2776.7596.465.2987.555
Selling & Marketing Expenses 165.561158.025147.231133.595195.897177.45924.64917.43319.96531.00828.87125.44423.22219.4919.45220.34513.9211.56312.21711.3598.0058.8727.3616.5712.3940.3931.485
SG&A 272.257256.369232.44209.422276.887291.60933.27924.87728.80240.02241.39336.98633.30930.28483.26379.23162.53971.74826.69171.27127.33719.04414.63713.338.8535.699.04
Other Expenses 205.346261.827311.882273.421199.01386.3210.4954.4613.223-0.3821.2165.14813.3527.3580.895.2196.483-29.289-4.896-3.952-2.8930.8430.5334.2660.2750.4210.17
Operating Expenses 1,114.9691,160.081,087.037906.031829.147807.84993.17278.72690.969111.899113.717109.241100.1980.91689.64385.75566.79675.88539.23272.31628.08719.8715.37413.5059.1656.1119.21
Operating Income 922.41,278.841933.832629.357511.809503.14864.20427.90539.43592.88686.6778.08664.03448.82248.34666.77947.1796.81610.702-29.6835.94413.18123.80720.9820.58718.64313.976
Operating Income Ratio 0.1170.1410.1260.1160.1090.120.1220.0710.0830.1530.1270.1190.1040.0990.0950.1110.0950.0190.037-0.1060.1860.0870.1670.1510.160.2010.119
Total Other Income Expenses Net 47.12756.45564.25797.655108.49694.4356.6454.3673.021-0.8891.2344.67513.0875.308-8.3494.46-15.97-30.645-5.926-8.641-2.8930.043-0.1750.961-0.00100
Income Before Tax 969.5271,335.296998.089727.012607.141589.46964.69932.27242.45691.99787.69782.76177.12154.1349.13671.23942.657-23.8294.776-33.63733.05113.22423.63324.09820.58618.64313.976
Income Before Tax Ratio 0.1230.1470.1340.1340.1290.1410.1230.0820.090.1510.1280.1260.1250.110.0970.1180.086-0.0650.016-0.120.1710.0870.1650.1740.160.2010.119
Income Tax Expense 69.492165.38594.95573.2370.29654.6185.8176.425-0.76514.39911.93112.67114.5249.2196.44912.41916.55811.5721.0490.20.0590.0090.0263.501-1.388-1.697-1.753
Net Income 899.8131,164.978891.462647.828525.063524.82258.88227.11143.21376.60174.6368.87261.23543.61141.37656.40923.744-37.0283.261-33.04533.66213.21523.59324.09820.58618.64313.976
Net Income Ratio 0.1150.1280.120.1190.1120.1260.1120.0690.0910.1260.1090.1050.10.0890.0820.0940.048-0.1010.011-0.1180.1740.0870.1650.1740.160.2010.119
EPS 0.991.290.990.720.640.630.390.090.150.260.250.230.210.150.140.190.083-0.130.009-0.120.0860.0340.060.0560.0720.0650.049
EPS Diluted 0.991.290.990.720.640.630.390.090.150.260.250.230.210.150.140.190.083-0.130.009-0.120.0860.0340.060.0560.0720.0650.049
EBITDA 1,458.8581,752.191,353.9971,046.579973.926909.008688.29848.97355.474111.77997.95790.85774.28475.71362.56184.51170.485-7.94220.667-19.39546.92624.63127.08530.35521.698-6.111-9.21
EBITDA Ratio 0.1860.1930.1820.1930.2070.2171.3060.1250.1170.1840.1430.1380.1210.1540.1230.140.142-0.0220.071-0.0690.2430.1620.190.2190.169-0.066-0.078